“We have the opportunity now to be at the forefront of research, not just in this country, but in the world,” Towle said.
Currently, if MedPharm wants to do any testing, they have to send their cannabis products to test subjects through a dispensary. Because dispensaries are required to include THC in their products, it eliminates the possibility of including a placebo in these studies. But by cutting out the middle man, Towle says they can go to their customers and subjects directly, allowing for more accurate research through randomized clinical trials.
Medpharm will get the green light and continue do be successful. The real question is when or if will they become part of mdcl? No news from medicine man...